Case Study: Sentinel Oncology achieves 2% FX savings and greater payment control with Money Mover

Sentinel Oncology - Customer Case Study

Sentinel Oncology, a Cambridge‑based drug discovery company developing new therapeutics for hard‑to‑treat cancers, had become increasingly international and needed to make frequent multi‑currency payments for outsourced scientific services. Concerned that foreign exchange costs were rising and that its banks offered little transparency or control, Sentinel engaged Money Mover, a disruptive FinTech providing a secure, transparent global payments service, to review its FX processes.

Money Mover analysed Sentinel’s recent payments and recommended changing how non‑GBP transfers were routed so Sentinel could control conversion timing and reduce hidden bank charges. By switching to Money Mover’s service Sentinel gained clearer pricing, easier administration after a straightforward onboarding, and measurable savings of around 2% on each payment, while reducing management time — benefits that convinced Sentinel Oncology to continue using Money Mover for non‑GBP payments and account transfers.

Sentinel Oncology

Bob Boyle

CEO